Cargando…

Baicalin Protects Against Hypertension-Associated Intestinal Barrier Impairment in Part Through Enhanced Microbial Production of Short-Chain Fatty Acids

Impaired intestinal barrier plays an important role in the pathogenesis of hypertension primarily through promoting the development of chronic low-grade inflammation. Baicalin is the major flavonoid component of Scutellaria baicalensis Georgi, a medicinal plant commonly used for the treatment of inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Dandan, Ding, Liliqiang, Tang, Xiaoting, Wang, Wenjian, Chen, Yu, Zhang, Teng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826474/
https://www.ncbi.nlm.nih.gov/pubmed/31719823
http://dx.doi.org/10.3389/fphar.2019.01271
_version_ 1783465095927431168
author Wu, Dandan
Ding, Liliqiang
Tang, Xiaoting
Wang, Wenjian
Chen, Yu
Zhang, Teng
author_facet Wu, Dandan
Ding, Liliqiang
Tang, Xiaoting
Wang, Wenjian
Chen, Yu
Zhang, Teng
author_sort Wu, Dandan
collection PubMed
description Impaired intestinal barrier plays an important role in the pathogenesis of hypertension primarily through promoting the development of chronic low-grade inflammation. Baicalin is the major flavonoid component of Scutellaria baicalensis Georgi, a medicinal plant commonly used for the treatment of inflammatory intestinal disorders and hypertension in traditional Chinese medicine. However, it remains to be elucidated whether baicalin alleviates hypertension-associated intestinal barrier impairment. The current study thus investigated the effects of baicalin on the intestinal barrier integrity, the intestinal expression of genes encoding proinflammatory factors and tight junction proteins, the serum levels of the inflammatory markers, the amount of fecal short-chain fatty acids (SCFAs) and the abundance of SCFAs-producing bacteria in the spontaneously hypertensive rats (SHRs). The results showed that baicalin alleviated the pathological lesions in the ilium and the proximal colon in the SHRs. Baicalin treatment resulted in decreased ileal and colonic expression of proinflammatory genes in the SHRs. In addition, baicalin treatment attenuated hypertension-associated intestinal hyperpermeability and decreased the serum levels of inflammatory indicators such as high-sensitivity C-reactive protein (hs-CRP), interleukin 1 beta, and IL-6 in the SHRs. The protective effect of baicalin on the intestinal integrity was also supported by well-preserved intestinal ultrastructure and increased intestinal expression of genes encoding tight junction proteins such as zonula occludens-1 (ZO-1), cingulin, and occludin in the SHRs. Lastly, baicalin treatment increased the amount of fecal SCFAs and the abundance of SCFAs-producing bacteria in the SHRs. In conclusion, the work here provides for the first time the morphological, biochemical, and molecular evidence supporting the protective effects of baicalin on the intestinal integrity in the SHRs, which may help better understand the therapeutic effects of S. baicalensis Georgi in the treatment of hypertension.
format Online
Article
Text
id pubmed-6826474
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-68264742019-11-12 Baicalin Protects Against Hypertension-Associated Intestinal Barrier Impairment in Part Through Enhanced Microbial Production of Short-Chain Fatty Acids Wu, Dandan Ding, Liliqiang Tang, Xiaoting Wang, Wenjian Chen, Yu Zhang, Teng Front Pharmacol Pharmacology Impaired intestinal barrier plays an important role in the pathogenesis of hypertension primarily through promoting the development of chronic low-grade inflammation. Baicalin is the major flavonoid component of Scutellaria baicalensis Georgi, a medicinal plant commonly used for the treatment of inflammatory intestinal disorders and hypertension in traditional Chinese medicine. However, it remains to be elucidated whether baicalin alleviates hypertension-associated intestinal barrier impairment. The current study thus investigated the effects of baicalin on the intestinal barrier integrity, the intestinal expression of genes encoding proinflammatory factors and tight junction proteins, the serum levels of the inflammatory markers, the amount of fecal short-chain fatty acids (SCFAs) and the abundance of SCFAs-producing bacteria in the spontaneously hypertensive rats (SHRs). The results showed that baicalin alleviated the pathological lesions in the ilium and the proximal colon in the SHRs. Baicalin treatment resulted in decreased ileal and colonic expression of proinflammatory genes in the SHRs. In addition, baicalin treatment attenuated hypertension-associated intestinal hyperpermeability and decreased the serum levels of inflammatory indicators such as high-sensitivity C-reactive protein (hs-CRP), interleukin 1 beta, and IL-6 in the SHRs. The protective effect of baicalin on the intestinal integrity was also supported by well-preserved intestinal ultrastructure and increased intestinal expression of genes encoding tight junction proteins such as zonula occludens-1 (ZO-1), cingulin, and occludin in the SHRs. Lastly, baicalin treatment increased the amount of fecal SCFAs and the abundance of SCFAs-producing bacteria in the SHRs. In conclusion, the work here provides for the first time the morphological, biochemical, and molecular evidence supporting the protective effects of baicalin on the intestinal integrity in the SHRs, which may help better understand the therapeutic effects of S. baicalensis Georgi in the treatment of hypertension. Frontiers Media S.A. 2019-10-28 /pmc/articles/PMC6826474/ /pubmed/31719823 http://dx.doi.org/10.3389/fphar.2019.01271 Text en Copyright © 2019 Wu, Ding, Tang, Wang, Chen and Zhang http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wu, Dandan
Ding, Liliqiang
Tang, Xiaoting
Wang, Wenjian
Chen, Yu
Zhang, Teng
Baicalin Protects Against Hypertension-Associated Intestinal Barrier Impairment in Part Through Enhanced Microbial Production of Short-Chain Fatty Acids
title Baicalin Protects Against Hypertension-Associated Intestinal Barrier Impairment in Part Through Enhanced Microbial Production of Short-Chain Fatty Acids
title_full Baicalin Protects Against Hypertension-Associated Intestinal Barrier Impairment in Part Through Enhanced Microbial Production of Short-Chain Fatty Acids
title_fullStr Baicalin Protects Against Hypertension-Associated Intestinal Barrier Impairment in Part Through Enhanced Microbial Production of Short-Chain Fatty Acids
title_full_unstemmed Baicalin Protects Against Hypertension-Associated Intestinal Barrier Impairment in Part Through Enhanced Microbial Production of Short-Chain Fatty Acids
title_short Baicalin Protects Against Hypertension-Associated Intestinal Barrier Impairment in Part Through Enhanced Microbial Production of Short-Chain Fatty Acids
title_sort baicalin protects against hypertension-associated intestinal barrier impairment in part through enhanced microbial production of short-chain fatty acids
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826474/
https://www.ncbi.nlm.nih.gov/pubmed/31719823
http://dx.doi.org/10.3389/fphar.2019.01271
work_keys_str_mv AT wudandan baicalinprotectsagainsthypertensionassociatedintestinalbarrierimpairmentinpartthroughenhancedmicrobialproductionofshortchainfattyacids
AT dingliliqiang baicalinprotectsagainsthypertensionassociatedintestinalbarrierimpairmentinpartthroughenhancedmicrobialproductionofshortchainfattyacids
AT tangxiaoting baicalinprotectsagainsthypertensionassociatedintestinalbarrierimpairmentinpartthroughenhancedmicrobialproductionofshortchainfattyacids
AT wangwenjian baicalinprotectsagainsthypertensionassociatedintestinalbarrierimpairmentinpartthroughenhancedmicrobialproductionofshortchainfattyacids
AT chenyu baicalinprotectsagainsthypertensionassociatedintestinalbarrierimpairmentinpartthroughenhancedmicrobialproductionofshortchainfattyacids
AT zhangteng baicalinprotectsagainsthypertensionassociatedintestinalbarrierimpairmentinpartthroughenhancedmicrobialproductionofshortchainfattyacids